The weekly round-up of news developments from Google Alerts, for Breast Cancer and Cancer, for the week ending 27 June 2014.
A surfeit of news articles this week, so I’ll just draw your attention to the first two: the first is a study on how limiting carbohydrate intake could cut down breast cancer recurrence in women with certain types of tumours. The question is: how do we find out whether or not our tumours are IGF1 receptor positive? It would go far in helping out sort the tricky diet dilemma for all breast cancer patients. There are a plethora of diets out there, some very high in carbs (e.g. Gerson with its juices) and their passionate advocates. However, what works for some women may not work for others, and this study underlines the fact that limiting carb intake (which is the foundation of many cancer diets) may not be effective for some.
The second article comes with a warning: distressing photos. A study on weedkiller and GMO corn causing tumours in mice has been confirmed as accurate. The study was first published two years ago and caused an uproar and withdrawn, it has since been reviewed and republished. I’m just puzzled that not more has been made of this study. Methinks Big Pharma may be behind this news mask.
Poison or Food? image credit: telegraph.co.uk
1. Limiting carbs could reduce breast cancer recurrence in women with positive IGF1 receptor
http://medicalxpress.com/news/2014-06-diet-affect-recurrence-breast-cancers.html Continue reading
Galega officinalis – source of Metformin
photo credit: wikipedia
If this post has helped you, please would you help me? I am now fundraising for cancer treatments at GoFundMe http://www.gofundme.com/78jh2w or JustGiving:
Updated 19 Jan 2014 with additional links to metformin and chemotherapy and radiotherapy, and dosage recommendations
Metformin is a drug that is usually used to control sugar level in people with Type 2 diabetes.
Tests have also shown that it may also be effective in reducing cancer risk, improving the survival of people with cancer, and inducing cancer cell death.
Metformin has been shown to selectively target and kill some lines of breast cancer stem cells. As stem cells are usually resistant to chemotherapy, metformin is another tool you want to have in your kit.
It is speculated that metformin works by blocking a metabolic stress response that stimulates the inflammatory pathway associated with a wide variety of cancers. Continue reading